{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:09:53Z","timestamp":1789052993167,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.ejso.2022.01.003","type":"journal-article","created":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T11:08:48Z","timestamp":1642763328000},"page":"1723-1729","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Treatment strategies and outcomes of primary Myxofibrosarcomas in a large patients cohort"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8181-3641","authenticated-orcid":false,"given":"Stefano","family":"Radaelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Pasquali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Callegaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Sanfilippo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Stacchiotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0425-4692","authenticated-orcid":false,"given":"Salvatore","family":"Provenzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Sangalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Morosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9728-3120","authenticated-orcid":false,"given":"Marta","family":"Barisella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalba","family":"Miceli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8220-424X","authenticated-orcid":false,"given":"Marco","family":"Fiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4703-3534","authenticated-orcid":false,"given":"Alessandro","family":"Gronchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2022.01.003_bib1","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1159\/000507334","article-title":"The biology of myxofibrosarcoma: state of the art and future perspectives","volume":"43","author":"Sambri","year":"2020","journal-title":"Oncol Res Treat"},{"key":"10.1016\/j.ejso.2022.01.003_bib2","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/SLA.0b013e3181cf87fa","article-title":"Extremity soft tissue sarcoma in a series of patients treated at a single institution: local control directly impacts survival","volume":"251","author":"Gronchi","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2022.01.003_bib3","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s00256-008-0542-4","article-title":"MRI and histological evaluation of the infiltrative growth pattern of myxofibrosarcoma","volume":"37","author":"Kaya","year":"2008","journal-title":"Skeletal Radiol"},{"key":"10.1016\/j.ejso.2022.01.003_bib4","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00256-012-1563-6","article-title":"Myxofibrosarcoma: prevalence and diagnostic value of the \"tail sign\" on magnetic resonance imaging","volume":"42","author":"Lefkowitz","year":"2013","journal-title":"Skeletal Radiol"},{"key":"10.1016\/j.ejso.2022.01.003_bib5","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/jso.23708","article-title":"Impact of infiltrative growth on the outcome of patients with undifferentiated pleomorphic sarcoma and myxofibrosarcoma","volume":"110","author":"Iwata","year":"2014","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2022.01.003_bib6","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.ejso.2020.11.144","article-title":"The role of surgical margin quality in myxofibrosarcoma and undifferentiated pleomorphic sarcoma","volume":"47","author":"Fujiwara","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2022.01.003_bib7","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1245\/s10434-016-5462-2","article-title":"Primary extremity soft tissue sarcomas: does local control impact survival?","volume":"24","author":"Bonvalot","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.01.003_bib8","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00000478-199604000-00001","article-title":"Myxofibrosarcoma. Clinicopathologic analysis of 75 cases with emphasis on the low-grade variant","volume":"20","author":"Mentzel","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejso.2022.01.003_bib9","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1245\/s10434-010-1341-4","article-title":"Myxofibrosarcoma: prognostic factors and survival in a series of patients treated at a single institution","volume":"18","author":"Sanfilippo","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.01.003_bib10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ijrobp.2010.08.042","article-title":"Recurrence patterns and survival for patients with intermediate- and high-grade myxofibrosarcoma","volume":"82","author":"Haglund","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejso.2022.01.003_bib11","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/cncr.26296","article-title":"The enigma of myxofibrosarcoma of the extremity","volume":"118","author":"Mutter","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2022.01.003_bib12","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1093\/jjco\/hyt119","article-title":"An analysis of factors related to recurrence of myxofibrosarcoma","volume":"43","author":"Kikuta","year":"2013","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.ejso.2022.01.003_bib13","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.ejso.2016.05.015","article-title":"Surgical margins do not affect prognosis in high grade myxofibrosarcoma","volume":"42","author":"Sambri","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2022.01.003_bib14","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/COC.0000000000000382","article-title":"Predictors of local recurrence in patients with myxofibrosarcoma","volume":"41","author":"Odei","year":"2018","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ejso.2022.01.003_bib15","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ijrobp.2018.05.055","article-title":"Localized myxofibrosarcomas: roles of surgical margins and adjuvant radiation therapy","volume":"102","author":"Boughzala-Bennadji","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejso.2022.01.003_bib16","doi-asserted-by":"crossref","first-page":"8517371","DOI":"10.1155\/2019\/8517371","article-title":"High recurrence rate of myxofibrosarcoma: the effect of radiotherapy is not clear","volume":"2019","author":"Teurneau","year":"2019","journal-title":"Sarcoma"},{"key":"10.1016\/j.ejso.2022.01.003_bib17","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000506844","article-title":"Grading in myxofibrosarcoma of the extremities can predict survival and local control","volume":"43","author":"Sambri","year":"2020","journal-title":"Oncol Res Treat"},{"key":"10.1016\/j.ejso.2022.01.003_bib18","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/jso.26277","article-title":"A\u00a0clinicopathologic examination of myxofibrosarcoma. Do surgical margins significantly affect local recurrence rates in this infiltrative sarcoma subtype?","volume":"123","author":"Dadrass","year":"2021","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2022.01.003_bib19","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1002\/bjs.10227","article-title":"Patterns of disease relapse in primary extremity soft-tissue sarcoma","volume":"103","author":"Smith","year":"2016","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2022.01.003_bib20","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/modpathol.3800550","article-title":"Local recurrence of myxofibrosarcoma is associated with increase in tumour grade and cytogenetic aberrations, suggesting a multistep tumour progression model","volume":"19","author":"Willems","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ejso.2022.01.003_bib21","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.soc.2016.05.008","article-title":"Myxofibrosarcoma","volume":"25","author":"Roland","year":"2016","journal-title":"Surg. Oncol. Clin. N Am."},{"key":"10.1016\/j.ejso.2022.01.003_bib22","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.annonc.2021.07.006","article-title":"Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up( )","volume":"32","author":"Gronchi","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2022.01.003_bib23","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/cncr.33895","article-title":"Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: a Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial","volume":"128","author":"Pasquali","year":"2022","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2022.01.003_bib24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejca.2018.12.009","article-title":"The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial","volume":"109","author":"Pasquali","year":"2019","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2022.01.003_bib25","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/annonc\/mdu459","article-title":"Rare Cancers Europe (RCE) methodological recommendations for clinical studies in rare cancers: a European consensus position paper","volume":"26","author":"Casali","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2022.01.003_bib26","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1200\/JCO.2017.74.6941","article-title":"Analysis of margin classification systems for assessing the risk of local recurrence after soft tissue sarcoma resection","volume":"36","author":"Gundle","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2022.01.003_bib27","first-page":"1","article-title":"Risk factors for the development of local recurrence in extremity soft-tissue sarcoma","author":"Tirotta","year":"2021","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.ejso.2022.01.003_bib28","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/PAS.0000000000001389","article-title":"Comparative study of myxofibrosarcoma with undifferentiated pleomorphic sarcoma: histopathologic and clinicopathologic review","volume":"44","author":"Yoshimoto","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejso.2022.01.003_bib29","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1245\/s10434-020-09564-6","article-title":"Unplanned excision of extremity and trunk wall soft tissue sarcoma: to Re-resect or not to Re-resect?","volume":"28","author":"Danieli","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.01.003_bib30","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1245\/s10434-019-07494-6","article-title":"Watch and wait approach for Re-excision after unplanned yet macroscopically complete excision of extremity and superficial truncal soft tissue sarcoma is safe and does not affect metastatic risk or amputation rate","volume":"26","author":"Decanter","year":"2019","journal-title":"Ann Surg Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074879832200004X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074879832200004X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:42:42Z","timestamp":1760060562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S074879832200004X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S074879832200004X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2022.01.003","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment strategies and outcomes of primary Myxofibrosarcomas in a large patients cohort","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2022.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}